These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38745200)

  • 1. Analyzing factors affecting positivity in drive-through COVID-19 testing: a cross-sectional study.
    Mori M; Yokoyama K; Sanuki R; Inoue F; Maekawa T; Moriyama T
    Virol J; 2024 May; 21(1):111. PubMed ID: 38745200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
    Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
    JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
    Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
    PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
    Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
    JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross sectional study of the clinical characteristics of French primary care patients with COVID-19.
    Sebo P; Tudrej B; Lourdaux J; Cuzin C; Floquet M; Haller DM; Maisonneuve H
    Sci Rep; 2021 Jun; 11(1):12492. PubMed ID: 34127693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis of the Clinical Presentation of Individuals Who Test Positive or Negative for SARS-CoV-2: Results from a Test Street Study.
    Kiani P; Hendriksen PA; Kim AJ; Garssen J; Verster JC
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
    Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
    Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological characteristics of patients seeking COVID-19 testing in a private centre in Malaysia: Is there a role for private healthcare in battling the outbreak?
    Chow YP; Chin BHZ; Loo JM; Moorthy LR; Jairaman J; Tan LH; Tay WWY
    PLoS One; 2021; 16(10):e0258671. PubMed ID: 34648575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of SARS-CoV-2 Positivity Based on RT-PCR Swab Tests at a Drive-Through Outpatient Clinic for COVID-19 Screening in Japan.
    Ishii T; Kushimoto S; Katori Y; Kure S; Igarashi K; Fujita M; Takayama S; Abe M; Tanaka J; Kikuchi A; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Akaishi T
    Tohoku J Exp Med; 2021 Feb; 253(2):101-108. PubMed ID: 33536379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for a positive SARS-CoV-2 PCR in patients with common cold symptoms in a primary care setting - a retrospective analysis based on a joint documentation standard.
    Just J; Puth MT; Regenold F; Weckbecker K; Bleckwenn M
    BMC Fam Pract; 2020 Dec; 21(1):251. PubMed ID: 33272198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study.
    Shang H; Chang T; Yang W; Shi L; Hu S; Tian L; Ren J; Wang T; Wang J; Guo J; Cui Y
    BMC Infect Dis; 2024 Jan; 24(1):36. PubMed ID: 38166694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Findings from the first public COVID-19 temporary test centre in Hong Kong.
    Leung WLH; Yu ELM; Wong SC; Leung M; Lee LLY; Chung KL; Cheng VCC
    Hong Kong Med J; 2021 Apr; 27(2):99-105. PubMed ID: 33790053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study.
    Kiran T; Craig-Neil A; Das P; Lockwood J; Wang R; Nathanielsz N; Rosenthal E; Snider C; Hwang SW
    CMAJ Open; 2021; 9(1):E302-E308. PubMed ID: 33785478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island.
    Joubert A; Andry F; Bertolotti A; Accot F; Koumar Y; Legrand F; Poubeau P; Manaquin R; Gérardin P; Levin C
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0008879. PubMed ID: 33901185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposed clinical indicators for efficient screening and testing for COVID-19 infection using Classification and Regression Trees (CART) analysis.
    Zimmerman RK; Nowalk MP; Bear T; Taber R; Clarke KS; Sax TM; Eng H; Clarke LG; Balasubramani GK
    Hum Vaccin Immunother; 2021 Apr; 17(4):1109-1112. PubMed ID: 33079625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.